ICYMI: At Hearing, Senator Murray Slams Trump Administration for Threatening Biomedical Research and Jeopardizing Americans’ Health
NIH Investments support more than $3 billion in economic activity across Washington State and more than 12,000 jobs – MORE HERE
***AUDIO HERE; PHOTOS and B-ROLL HERE***
Seattle, WA— Today, U.S. Senator Patty Murray (D-WA), Vice Chair of the Senate Appropriations Committee, held a roundtable discussion in Seattle highlighting why the investments the federal government makes in biomedical research are so vital, what’s at stake for patients and families as Trump takes a wrecking ball to this research, and why Congress must forcefully push back. Murray was joined by Seattle area leaders in biomedical research of national renown, patients who have benefitted directly from NIH research, and early career researchers who can speak directly to how Trump’s cuts and chaos are jeopardizing the future of biomedical research in America.
During the roundtable, Senator Murray was joined by Dr. Jeff Sperring, Seattle Children’s Chief Executive Officer; Dr. Vittorio Gallo, Seattle Children’s Chief Scientific Officer; Dr. Mary-Claire King, American Cancer Society Professor of Medicine and Genome Sciences, UW School of Medicine; Dr. Jane Hoyt Buckner, M.D., President of Benaroya Research Institute; Kristin Weinstein, PhD candidate at UW School of Medicine; and Alisa Vitello along with her daughter, Olivia Vitello, who benefitted from medication developed through an NIH clinical trial.
President Trump and his administration has systematically undermined NIH and the research it funds, which is having devastating impacts on biomedical research, innovation, and ultimately, the lives of millions of patients and families. The Trump administration’s actions are delaying funding and stalling research for lifesaving treatments and cures, weakening our biomedical workforce, cancelling vital ongoing studies and trials, and threatening to undo decades of hard-won progress.
“Medical research is an economic powerhouse—it supports millions of jobs across the country, especially here in Washington state, and generates billions in economic activity. NIH funding is the cornerstone of our medical research enterprise, while medical research accounts for less than 1 percent of the federal budget, NIH has contributed to over 99 percent of drugs approved by FDA in recent years,” said Senator Murray. “But the real impact isn’t economic, it isn’t jobs, it isn’t awards, it is miracles that give people hope and more time with loved ones. That could mean a new vaccine to protect us from a disease. It could mean new treatment that saves lives. Or a breakthrough discovery that revolutionizes care and research, like Dr. King’s work showing a gene tied to breast cancer.”
“That is all invaluable—but with President Trump—it is all on the chopping block,” continued Senator Murray. “He has already axed 800 grants, over a billion dollars in research for HIV prevention, breast cancer, pregnancy, diabetes, Alzheimer’s, and more. He has also blocked $2 billion in grant funding from going out to universities and research institutions across the country.He slapped a $1 limit on NIH researchers’ payment cards—meaning labs can’t get gloves, pipettes, and vials—the basics they need to keep research going.He wants to massively cut funding for basic costs that keep labs running.And Trump is calling for at least an $18 billion cut to NIH funding. And it’s not just funding Trump has cut—it’s the workforce. Trump has pushed out nearly 5,000 people at NIH and counting.He is slashing grants to support early educators. And he is pushing out and scaring away international students. We are seeing canceled trials and delayed research. We must keep up the public pressure. People need to know what is happening. They need to know what is at stake.”
Murray’s roundtable discussion follows a bipartisan Senate Appropriations Committee hearing she co-led this week, where she invited testimony from Washington state mom and patient advocate, Emily Stenson, whose daughter Charlie was diagnosed with stage 4 cancer at just three years old but who, thanks to a National Cancer Institute clinical trial at Seattle Children’s Hospital, has been cancer free since December 2024.
“Children are our future, and we drive advances—like improving survival rates for children with brain tumors, developing new therapies for rare diseases, and transforming care for kids with complex behavioral health needs—through research,” said Dr. Vittorio Gallo, Chief Scientific Officer at Seattle Children’s. “Without sustained NIH investment, nearly 200 clinical trials at Seattle Children’s could be delayed or paused. Funding is critical for us to deliver on our mission to provide hope, care and cures.”
“I wanted to first tell you what’s happened to me in consequence of this craziness. I am now owed—4 months later—$1.8 million of a noncompetitive renewal on a project that has been approved at all scientific levels. The Notice of Grant Award has been signed. It was to begin last January 1. It has simply not been sent. It’s not canceled. It just hasn’t come. Somehow it is frozen. No reason has been given. There is no DEI component, it’s only sequencing of DNA…There are probably thousands more like me. That estimate of the of the total cost—the total deficit into those 800 [grants]—I think is only a very small fraction of the actual amount of money that we need as researchers, that has been guaranteed for us. They will need to burn this money if they don’t send it. This money is allocated to the University of Washington. They can’t use it for anything else. They might as well take out the bills and just burn them. In addition to the research itself, it supports 4 young investigators. We’re now 4 months in with their having no salaries from that grant. I’m using my own salary, I’m using gifts that I’ve been accumulating for 50 years to pay them. So far so good, but we’ll run out pretty quickly. Grants like this need to be dislodged from the iceberg in which they are now frozen,” said Dr. Mary-Claire King, American Cancer Society Professor of Medicine and Genome Sciences at UW School of Medicine. Dr. King was the first person to show that breast cancer can be inherited due to mutations in the gene she called BRCA1. Dr. King also shared the story of a woman who participated in one of her projects, “She said, ‘My mother died of breast cancer when I was 14. She missed my high school graduation. She missed the decisions about my going to college. She missed my college graduation. She missed my marriage. She missed the birth of her granddaughter. When I learned that it was possible to have testing to learn if I was predisposed to breast cancer, I was tested right away. I have a mutation in BRCA 1, that surely is what killed her. As soon as I was old enough, I had the same surgery that Angelina Jolie had, and I am now fine. My daughter graduates from high school this June, and I will be there. Just thought, you want to know.’ We owe it to her to bring the NIH back to health. So, thanks very much for what you’re doing.”
“We study immune diseases, particularly autoimmune diseases and allergies. [Autoimmune diseases] affect 25 to 50 million Americans. [Allergies] affect 25% of Americans, in fact two kids in every classroom. And we’re funded 70% by the National Institute of Health, and that work you know, that supports fundamentally understanding these diseases and also clinical trials to test the next new therapy. As well as ways to prevent ever getting a disease like type one diabetes. We want kids never to have to face using insulin every day…I do this because I’m also a physician and a rheumatologist, so I care for people with arthritis, and I’ve been doing that for 30 years. And for the first 10 years of my career, we didn’t have much for my patients and our waiting rooms were filled with wheelchairs. You had to reorganize furniture for our patients. And then drugs called biologics were discovered—in fact, one of the first ones came from the Seattle area—and literally, patients got out of wheelchairs and walked in a week. That research started 30 years before, and that was funded by NIH research, and it would have actually never become a product if those studies hadn’t been done. Today, I still see patients with rheumatoid arthritis, and they’re doing so much better. We don’t have wheelchairs in our waiting rooms anymore,” said Dr. Jane Hoyt Buckner, M.D., President of Benaroya Research Institute. “You may not know you need the cure that is going to be discovered through this research, but in 10 years you may, or your family member may, and by not funding the NIH, some of those cures won’t be there in 10 years. And I also think some of our young people who are trying to choose a career in science are going to be turned away. And it’s only been 100 days, but the chaos that’s been created in that 100 days is already impacting people. We see it now, people choosing not to go to graduate school, people choosing alternative careers, scientists thinking I should move out of the United States. And I can also say I’m fortunate to work very closely with many people at the NIH, particularly on clinical trials trying to cure diseases of the immune system, and they are struggling to continue to do that work. They’re understaffed, they aren’t able to get things out, and they don’t know what’s going to happen next. I know they’re really looking to Congress to help us find a way out of this.”
“Unstable funding from the NIH for biomedical research will have long-lasting, devastating impacts. Early career scientists like myself will be forced to go abroad to continue our training, patients will unnecessarily suffer or die from the diseases that this research could cure, and the United States will cede its position as the global leader in biomedical research,” said Kristin Weinstein, PhD candidate at UW School of Medicine. “I am holding onto the hope that the American public and its leadership will recognize the vital importance of biomedical research, reinstate federal funding for this work, and support our hard-working scientists. At the end of the day, I just want to be in the lab doing what I love most: Making scientific discoveries that will lead to cures for diseases like cancer and autoimmunity.”
Trump and Elon Musk’s DOGE have terminated nearly 800 NIH grants across the country, cutting off more than $1.1 billion in essential research and trials and continue to terminate more grants every week. So far this year, he has slow walked roughly $2 billion in vital NIH funding that should be going out the door to fund the research that might discover the next treatment or cure that will change—or save—a patient’s life.
These grant terminations are a result of the Trump Administration’s Executive Orders against whatever it deems DEI and targeted attacks on specific academic research institutions, which are disrupting landmark diabetes research, targeting promising mRNA vaccines, and spreading vaccine hesitancy amidst a measles outbreak. A full list of HHS grant terminations can be found here. To date, NIH grant terminations include:
- Grants that fund research on HIV prevention, breast cancer, uterine cancer, stroke risk, cardiac health, suicide prevention, smoking cessation, eating disorders, COVID-19, pain, alcohol use disorder, depression, violence prevention in children, pregnancy health disparities, diabetes and obesity, and Alzheimer’s disease;
- More than 270 grants totaling at least $125 million for research focused on improving the health of LGBTQ Americans;
- Stop work orders for all NIH training grants that support diverse undergraduate and graduate students and early career scientists, including the Undergraduate Research Training Initiative for Student Enhancement (U-RISE), the Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC), and F31 Diversity training programs.
The Trump Administration’s actions, including directly terminating early career training programs funded by NIH, are devastating the pipeline of early career researchers and threatening the next generation of breakthroughs, treatments, and cures. On March 31st, an open letter signed by nearly 2,000 of the country’s top scientists including a number of Nobel Prize winners urged the Administration to stop its wholesale assault on U.S. science, which is decimating research, driving scientists to leave the country and putting America at risk of losing a generation of scientists.
Trump has illegally sought to cut billions in funding for universities to conduct this vital research by illegally capping the indirect cost rate in direct violation of bipartisan appropriations law—a federal judge has issued a nationwide injunction against the cap on indirect costs, but the Trump administration is appealing the ruling. The uncertainty around NIH’s indirect cost rate policy has led universities and research institutions around the country to implement hiring freezes, rescind graduate student admissions offers, and shutter entire graduate school programs.
President Trump has pushed out nearly 5,000 NIH employees and 4,000 FDA employees—decimating the very work responsible for discovering lifechanging treatments and cures and ensuring they can safely get to market. He also reportedly plans to propose to nearly halve NIH’s budget.
Senator Murray has been leading the charge against the Trump administration’s efforts to gut lifesaving research at NIH and pushed out nearly 5,000 NIH skilled scientists, grants administrators, and other employees at the agency. When the Trump administration attempted to illegally cap indirect cost rates at 15 percent, Senator Murray immediately and forcefully condemned the move, led the entire Senate Democratic caucus in a letter decrying the proposed change, and introduced amendments to Senate Republicans’ budget resolution to reverse it, which Republicans blocked.
As a longtime appropriator and former Chair of the Senate HELP Committee, Murray has led Congressional efforts to boost biomedical research. Previously, over her years as Chair of the Labor-HHS Appropriations Subcommittee, Senator Murray secured billions of dollars in increases for biomedical research at NIH, and during her time as Chair of the HELP Committee she established the new ARPA-H research agency as part of her PREVENT Pandemics Act to advance some of the most cutting-edge research in the field. Senator Murray was also the lead Democratic negotiator of the bipartisan 21st Century Cures Act, which delivered a major federal investment to boost NIH research, among many other investments.
###
